ALENTIS Therapeutics launches raising CHF 12.5m in a Series A to develop novel therapeutics in advanced liver disease and cancer.

Press/Media

Period	30 Apr 2019

Media coverage

Title	ALENTIS Therapeutics launches raising CHF 12.5m in a Series A to develop novel therapeutics in advanced liver disease and cancer.
Media name/outlet	BioPortfolio
Country/Territory	United Kingdom
Date	30/04/19
URL	https://www.bioportfolio.com/news/article/3970332/ALENTIS-Therapeutics-launches-raising-CHF-12-5m-in-a-Series-A-to.html
Persons	Yujin Hoshida